NCT04800588 · RECRUITING

Computerized Tests of Cognitive Decline in Presymptomatic Alzheimer's Disease

This trial is testing a new set of computerized cognitive assessments called the California Cognitive Assessment Battery. Researchers want to establish normal performance benchmarks across different ages, so the tests can eventually flag early signs of cognitive decline. It is not a drug trial — it is a diagnostic study, meaning it is testing a measuring tool, not a treatment. There is no experimental intervention here beyond taking the tests themselves.

You may qualify if

  • Must be able to use computer mouse and touch screen
  • Must speak English as a primary language
  • Must speak Spanish as a primary language (for Latino participants completing our Spanish translation)

You're excluded if

  • History of psychiatric disorder
  • History of stroke or transient ischemic attack
  • History of substance abuse
  • History of medical or sensory disorders that are incompatible with effective testing
  • History of traumatic brain injury with hospitalization and extended loss of consciousness
  • History of epilepsy
  • History of depression or anxiety

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2025-05-22

View full record on ClinicalTrials.gov

All APOE4 clinical trials